Paying For Essentials: Fight Brewing Over Specialty Tiers In Exchange Plans

Biopharmaceutical companies, patient groups and other stakeholders are pushing for federal guidelines specifically barring the use of formulary specialty tiers in private health insurance plans for individuals and small groups.